Tackling Variability in CNS Clinical Trials
Enhancing data reliability in neuroscience studies through structured rater training and integrated eCOA solutions. Central Nervous System (CNS) clinical trials are among the most complex to execute, with subjective endpoints and rater-dependent assessments introducing significant variability into study data. This variability can compromise data quality, increase operational burden, and ultimately impact the success of the trial.
In this session, we will explore practical strategies to designing and delivering rater training that supports consistency across sites and reduces operational burden. We will discuss how structured, scalable rater training programs, combined with strong oversight and governance, can enhance consistency, reduce rework, and support more predictable study outcomes. A key focus will also be on the critical role of eCOA platforms in this ecosystem. We will illustrate how flexible, study-adapted eCOA solutions, can align training, assessment workflow, and data capture in real-world conditions. By bridging the gap between training and execution, eCOA integration helps ensure data consistency from the first patient visit through to database lock.
Attendees will gain actionable insights on how to design more robust, integrated approaches to rater management and data collection; ultimately supporting higher-quality data and more confident decision-making in CNS trials.
until the webinar
Daniel Herron & Estelle Haenel
Global VP, Digital Health @RWS Group & CMO @Kayentis
Save your seat 👇
Proven approaches to reducing rater variability in complex CNS studies.
Ask Daniel Herron and Estelle Haenel your questions directly during the session.
With a strong focus on strategic initiatives and building trusted customer relationships, Dan leads efforts to bring innovative technology solutions to life sciences organisations, helping accelerate better outcomes for patients worldwide.
Joined Kayentis as Chief Medical Officer in 2019 – She has 25+ years of experience in pre-clinical and clinical research in Top 5 Pharma and Biotech companies. A Doctor of Pharmacy, Estelle also has Masters in Endocrinology and Cellular Interaction and a PhD in Biochemistry and Molecular Biology.
As host and moderator, Peter will lead the session, facilitating expert discussion and ensuring a valuable experience, with opportunities for participants to ask questions and engage.